Hirtle Callaghan & Co’s Cardinal Health CAH Stock Holding History

Hirtle Callaghan & Co’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,788	Closed	-$160K	–	172
2015 Q4	$160K	Hold	1,788	–	–	0.04%	68
2015 Q3	$137K	Hold	1,788	–	–	0.02%	103
2015 Q2	$150K	Buy	+1,788	New	+$158K	0.05%	104
2014 Q3	–	Sell	-312	Closed	-$21K	–	569
2014 Q2	$21K	Hold	312	–	–	﹤0.01%	453
2014 Q1	$22K	Hold	312	–	–	﹤0.01%	443
2013 Q4	$21K	Hold	312	–	–	﹤0.01%	420
2013 Q3	$16K	Buy	+312	New	+$15.8K	﹤0.01%	449

Other funds holding CAH

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hirtle Callaghan & Co's CAH Position: Q1 2016 in Review

Hirtle Callaghan & Co sold out of Cardinal Health (CAH) in Q1 2016, closing a stake of 1,788 shares — an estimated $160K sold.

Hirtle Callaghan & Co first reported a position in CAH in Q3 2013 and held it in 7 quarters. The position peaked at $160K in Q4 2015. 794 funds tracked by Wall St. Rank hold CAH as of Q1 2016.

Hirtle Callaghan & Co reported no remaining Cardinal Health position as of Q1 2016 after selling out during the quarter.
Hirtle Callaghan & Co sold 1,788 Cardinal Health shares in Q1 2016, an estimated $160K.
Hirtle Callaghan & Co first reported a position in Cardinal Health in Q3 2013 and held it in 7 quarters.
Hirtle Callaghan & Co's Cardinal Health position peaked at $160K in Q4 2015.
794 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2016.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2016, filed 6 May 2016.